Photo-driven theranostics, also known as phototheranostics, relying on the diverse excited-
state energy conversions of theranostic agents upon photoexcitation represents a significant …

Mitochondria are not only the main energy source of the cell but are also involved in the
regulation of important physiology and processes of diseases including cancers. Therefore …

Aggregation induced emission (AIE) photosensitizers have attracted great attention due to
their good performance in photodynamic therapy (PDT). However, the therapeutic effect of …

Organelle-targeted activatable photosensitizers are attractive to improve the specificity and
controllability of photodynamic therapy (PDT), however, they suffer from a big problem in the …

Thermally activated delayed fluorescence (TADF) materials with extremely small singlet‐
triplet energy offsets have opened new horizons for the development of metal‐free …

The development of boron delivery agents bearing an imaging capability is crucial for boron
neutron capture therapy (BNCT), yet it has been rarely explored. Here we present a new …

The design of novel nanomaterials and nanoprobes used to diagnose and treat
innumerable diseases has exhibited great potential in biomedical fields, which further …

Aggregation-induced emission (AIE) fluorogens produce strong, stable fluorescence upon
aggregation, thus enabling a new frontier in bio-detection, cell imaging, and other …

Ferroptosis, a completely new form of regulated cell death, is mainly caused by an
imbalance between oxidative damage and reductive protection and has shown great anti …

Luminogens with aggregation-induced emission (AIEgens) have been widely applied in the
field of photodynamic therapy. Among them, aggregation-induced emission photosensitizers …